Docetaxel Plus Oxaliplatin as Therapy in Patients With Pancreatic Cancer


NCT00690300

Interventional

Phase 2

Unknown status
The purpose of this study is to test a combination-therapy of oxaliplatin and docetaxel in patients with metastatic or locally advanced adenocarcinoma of the pancreas after failure of a palliative first line therapy.
Jan 31,2008
All
18 Years
N/A
44

In order to facilitate the use of our website, we use cookies.

Please confirm if you accept our tracking cookies. When declining the cookies, you can continue visiting the website without sending data to third party services. Read our complete cookie statement here.